Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy

(2011) Hongjiang Yan et al.   ACTA RADIOLOGICA

Prognostic significance of metabolic parameters measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer

(2011) Dongyuan Zhu et al.   LUNG CANCER

Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications

(2010) Ho Yun Lee et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer

(2010) Hyun Hoon Chung et al.   GYNECOLOGIC ONCOLOGY

The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer

(2010) Eric Vallières et al.   Journal of Thoracic Oncology

Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma

(2009) Seung Hyup Hyun et al.   ANNALS OF SURGICAL ONCOLOGY

High Tumor Metabolic Activity as Measured by Fluorodeoxyglucose Positron Emission Tomography Is Associated with Poor Prognosis in Limited and Extensive Stage Small-Cell Lung Cancer

(2009) Y. J. Lee et al.   CLINICAL CANCER RESEARCH

Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer

(2009) M. K. Chung et al.   CLINICAL CANCER RESEARCH

Radiotherapy for small-cell lung cancer—Where are we heading?

(2008) N.A. Bayman et al.   LUNG CANCER